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Letter to the Editor
Humoral Immunity against Bordetella pertussis: Antibodies or B Cells?
Kirimanjeswara et al. (5) studied the role of B cells and
antibodies in immunity to Bordetella by using murine infection
models for Bordetella bronchiseptica and the human pathogens
B. pertussis and B. parapertussis. They showed that although B
cells are required for efficient clearance of all three Bordetella
species, intraperitoneal injection of murine immune sera re-
sults in clearance of B. bronchiseptica, whereas the human
pathogens persist. From these data and results of previously
published studies which failed to show opsonic activity of hu-
man immune sera in vitro (7), they conclude that Bordetella
species that are pathogenic for humans may have acquired the
capacity to evade the human humoral immune response (5).
The study by Kirimanjeswara and colleagues is a valuable con-
tribution to the field. However, an alternative explanation for
their results should not remain unmentioned.
Recently published studies have clearly shown that human
immune sera efficiently induce leukocyte effector functions to-
wards B. pertussis (6). Bordetella-specific immunoglobulin G
(IgG) and IgA were shown to be capable of inducing phago-
cytosis, respiratory burst, and bacterial killing (2, 6). It was
furthermore shown that B. pertussis is less efficiently cleared
from mice deficient for IgG receptors (FcgR) (3, 4), which
suggests that IgG is also crucial for the induction of leukocyte
effector functions in vivo. Taken together, these data challenge
the conclusion by Kirimanjeswara et al. that Bordetella species
that are pathogenic for humans have acquired the capacity to
evade humoral immune responses.
We feel that data from studies using the combination of
inbred mouse strains and human pathogens should be inter-
preted with care. Their limited major histocompatibility com-
plex repertoire may preclude the generation of a specific im-
mune response of sufficient diversity, which is required for
efficient host defense. Although Kirimanjeswara et al. showed
that antibody titers and IgG subclass profiles did not differ
between mice infected with murine Bordetella pathogens and
those infected with human Bordetella pathogens (5), they did
not document antibody specificities. Importantly, recent stud-
ies showed that not all Bordetella-specific antibodies trigger
phagocyte effector functions; rather, opsonic activity of sera
primarily depends on the presence of specific antibody subsets.
Only pertactin-specific antibodies in human immune sera dis-
played opsonic activity and induced phagocytosis by human
leukocytes (1). Although it remains to be established which B.
bronchiseptica-specific antibodies (pertactin specific or others)
display opsonic activity, documenting the specificity in addition
to antibody titers in sera from mice seems mandatory for the
interpretation of the results obtained by Kirimanjeswara et al.
We look forward to sharing this information with them in the
near future.
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Authors’ Reply
We are in agreement with Drs. Rodriguez and van der Pol
that antibodies are important in the clearance of B. pertussis, as
demonstrated in our paper and previously by multiple groups.
Our discussion focused on the observation that adoptively
transferred antibodies clear B. bronchiseptica, but not B. per-
tussis, within 3 days, and we offer differential antigen recogni-
tion as one possible explanation. It is well-established that
adoptively transferred antibodies require more than 1 week to
clear B. pertussis from naive mice, and the contribution of
different antigens is a topic of investigation in multiple
laboratories.
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